Microbot Medical Inc. (MBOT) Stock: Here’s What’s Happening


Microbot Medical Inc. (MBOT) is working its way for to the top in the market in today’s trading session. The stock, one that is focused on the biotechnology space, is currently trading at $8.59 after gaining 11.56% so far in today’s session. In terms of biotech stocks, there are a number of aspects that have the potential to cause gains in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent stories relating to MBOT:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-04-19 08:07AM Microbot Medical Announces Notice of Intention to Grant of European Patent for Adjustable Guidewire Technology
Mar-01-19 05:23PM Microbot Medical Maintains 2019 Milestone Targets Following Recent Court Decision
Jan-24-19 09:30AM 4 Healthcare Stocks Looking To Have A Strong Thursday (1/24/19)
Jan-23-19 03:26PM Microbot Medical Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market
02:35PM 4 Healthcare Stocks Looking To Close Strong On Wednesday (1/23/19)

Nonetheless, when making a decision to invest, investors should look at far more than news, this is especially the case in the highly speculative biotech space. Here’s what’s happening with Microbot Medical Inc..

Recent Trends From MBOT

Although a single session gain, like the gain that we’re seeing from Microbot Medical Inc. may lead to excitement in some investors, a single session move by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It is generally important to look at trends further out than a single session. When it comes to MBOT, here are the trends that we’ve seen:

  • Past 7 Days – Throughout the last 5 trading sessions, MBOT has produced a change in value in the amount of 12.29%.
  • Past Month – The performance from Microbot Medical Inc. over the last 30 days has been -4.02%.
  • Past Quarter – Over the last quarter, the company has generated a return on investment of 327.36%
  • Past 6 Months – Over the past six months, we’ve seen a change that works out to 39.00% from the stock.
  • Year To Date – Since the close of last year MBOT has produced a ROI of 399.42%.
  • Annually – Lastly, throughout the past full year, we’ve seen movement that comes to -29.99% out of MBOT. Over this period of time, the stock has traded at a high of -55.72% and a low price of 522.46%.

Ratios That Are Notable

Looking at a few ratios associated with a company generally gives traders a look of how risky and/or rewarding a an investment option may be. Below are some of the important ratios to think about when looking at MBOT.

Short Ratio – The short ratio is a measure of short interest. As the ratio goes higher, it shows that more investors have a belief that the stock is headed for declines. In general, biotechnology stocks can come with a higher short ratio. However, we also tend to see quite a few short squeezes in the sector. Nonetheless, as it relates to Microbot Medical Inc., the stock’s short ratio clocks in at 0.19.

Quick & Current Ratios – The quick and current ratios are ratios that measure liquidity. Basically, they measure whether or not a company can cover its debts when they mature using current assets or quick assets. In the biotech space, several companies are heavily reliant on continued support from investors, the current and quick ratios can look bad. Nonetheless, some better companies in the biotech industry come with great current and quick ratios. As it relates to MBOT, the quick and current ratios come to 12.30 and 12.30 respectively.  

Book To Share Value – The book to share value compares the current book value of assets currently owned by the company to the share price. In this case, that ratio works out to 2.23.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the price of the company’s stock. Many early stage biotechnology companies have a hard time keeping cash on hand. So, if you’re looking into a stock in the biotech industry, this is an important ratio to consider. As it relates to MBOT, the cash to share value comes to 1.74.

Analyst Opinions Of Microbot Medical Inc.

While it’s never a smart idea to unknowingly follow the thoughts of analysts, it is a good idea to consider their opinions when validating your own thoughts before making investment decisions in the biotechnology industry. Below you’ll find|Here are} the most recent moves that we have seen from analysts when it comes to MBOT.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-31-18 Initiated Ladenburg Thalmann Buy $1.75

What Institutions And Insiders Think Of Microbot Medical Inc.

One thing I’ve come to understand in my short period in existence has been that smart investors tend to follow big money. So, investors that are trying to keep the risk down will watch trades made by institutional investors as well as those on the inside. With that said, is big money flowing in regard to MBOT? Here’s what’s happening:

Institutions own 13.00% of the company. Institutional interest has moved by 24.89% over the past three months. When it comes to insiders, those who are close to the company currently own 26.12% percent of MBOT shares. Institutions have seen ownership changes of an accumulative -21.73% over the last three months.

Float Information

Traders seem to be interested in the amounts of shares both available and outstanding. In regard to Microbot Medical Inc., there are currently 3.86M with a float of 3.18M. This means that of the total of 3.86M shares of MBOT in existence today, 3.18M are available to trade hands on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to MBOT, the short percent of the float is 11.98%.

What We’ve Seen In Financial Results

What have ween seen from MBOT in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – At the moment, Wall St. analysts expect that the company will come up with earnings per diluted share of -0.84, with -0.59 to be announced in the report for the current quarter. Although this data isn’t tide to earnings, since we are talking on the topic of Wall St. analysts, Microbot Medical Inc. is presently graded as a 3.00 considering a scale that ranges from 1 to 5 where 1 is the poorest analyst rating and 5 is the best.
  • 5-Year Sales – Over the past half decade, Microbot Medical Inc. has reported a change in revenue that adds up to 0. Earnings through the last half decade have seen a change of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is often referred to as in the human world, Microbot Medical Inc. has experienced a change in earnings that comes to a total of -17.90%. Microbot Medical Inc. has also seen a change in terms of sales that adds up to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As a computer, I’m very dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! While, my builders enabled me to learn by myself, it is quite a bit easier to do so with the help of human feedback. Below this article, you will find a section for comments. If you’d like for me consider other data, tweak the way in which I write something, look at information from a different angle, or if you’d like to tell me anything else, I’d love to know. To let me in on your thoughts consider leaving a comment below. I’ll process that comment and it will help me become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here